Phibro Animal Health Corporation ( PAHC ) NASDAQ Global Market

Cena: 32.4 ( 2.69% )

Aktualizacja 08-22 21:58
NASDAQ Global Market
Branża: Drug Manufacturers - Specialty & Generic
Finanse
Rachunek zysków i strat
Bilans
Przepływy pieniężne
Prognozy
Statystyki
Dywidendy
Rekomendacje
Modele wyceny
Wskaźniki
Analiza techniczna

Notowania:

Opis firmy:

Phibro Animal Health Corporation rozwija, produkuje i dostarcza szereg produktów do zdrowia zwierząt i minerałów żywieniowych dla zwierząt gospodarskich przede wszystkim w Stanach Zjednoczonych. Działa w trzech segmentach: zdrowia zwierząt, żywienia mineralnego i produktów wydajnościowych. Firma rozwija, produkuje i sprzedaje produkty dla szeregu zwierząt spożywczych, w tym drobiu, świń, bydła wołowiny i mleczarskiego oraz akwakultury. Jego produkty zdrowia zwierząt obejmują również przeciwbakteryjne produkty biologiczne lub chemiczne stosowane w branży zdrowia zwierząt w celu leczenia lub zapobiegania chorobom bakteryjnym; antykokrzyńcze stosowane przede wszystkim do zapobiegania i kontrolowania choroby kokcidiozy u drobiu i bydła; Angleminowość w leczeniu infestacji pasożytniczych robaków jelitowych; oraz produkty przeciwblosowe dla bydła do kontrolowania wzdęcia u zwierząt wypasających się na rośliny strączkowej lub pszenicy. Ponadto firma oferuje specjalne produkty żywieniowe, które zwiększają żywienie, aby poprawić zdrowie i wydajność; oraz szczepionki zapobiegające chorobom przede wszystkim na rynkach drobiu i świń. Ponadto produkuje preparaty i rynki i stężenia śladowych minerałów, takich jak cynk, mangan, miedź, żelazo i inne związki; oraz różne specjalne składniki do użytku w branży opieki osobistej, przemysłowej chemikaliów i chemikaliów. Firma sprzedaje swoje zwierzęta zdrowia i mineralne produkty żywieniowe za pośrednictwem lokalnych biur sprzedaży do zintegrowanego drobiu, świń i bydła, a także przez komercyjnych producentów karmy dla zwierząt, hurtowników i dystrybutorów. Działa w Stanach Zjednoczonych, Ameryce Łacińskiej, Kanadzie, Europie, na Bliskim Wschodzie, Afryce i Azji i Pacyfiku. Firma była wcześniej znana jako Philipp Brothers Chemicals, Inc. i zmieniła nazwę na Phibro Animal Health Corporation w lipcu 2003 r. Phibro Animal Health Corporation został zarejestrowany w 2014 roku i ma siedzibę w Teaneck, New Jersey.

Informacje o spółce:
Sektor: Zdrowie
Branża: Drug Manufacturers - Specialty & Generic
Zatrudnienie: 1 940
Giełda: NASDAQ Global Market
Ilość akcji w obrocie: 99.4568
Ilość akcji: Brak danych
Debiut giełdowy: 2014-04-11
WWW: https://www.pahc.com
CEO: Mr. Jack Clifford Bendheim
Adres: Glenpointe Centre East
Siedziba: 07666-6712 Teaneck
ISIN: US71742Q1067
Wskaźniki finansowe
Kapitalizacja (USD) 1 313 288 608
Aktywa: 966 289 000
Cena: 32.4
Wskaźnik Altman Z-Score: 3.0
Stabilny (niskie ryzyko bankructwa)
Dywidenda: 0
P/E: 41.5
Ilość akcji w obrocie: 99%
Średni wolumen: 280 877
Ilość akcji 40 533 599
Wskaźniki finansowe
Przychody TTM 1 046 762 000
Zobowiązania: 707 762 000
Przedział 52 tyg.: 16.16 - 32.9484
Piotroski F-Score: 7
Silny (dobra jakość finansowa)
EPS: 0.8
P/E branży: 22.5
Beta: 0.51
Raport okresowy: 2025-08-27
WWW: https://www.pahc.com
Zarząd
Imie i Nazwisko Stanowisko Wynagrodzenie Rok urodzenia
Mr. Larry L. Miller Chief Operating Officer 774 914 1964
Mr. Rob Aukerman President of North America Region 619 272 1958
Mr. Daniel M. Bendheim Executive Vice President of Corporate Strategy & Director 548 176 1972
Mr. Jack Clifford Bendheim Chairman, President & Chief Executive Officer 2 895 188 1947
Mr. Glenn C. David Chief Financial Officer 0 1973
Mr. Jonathan Bendheim President of MACIE Region, GM of Israel Operations & Director 0 1976
Ms. Judith A. Weinstein Senior Vice President, General Counsel & Corporate Secretary 0 1969
Mr. Samson Li President of Asia Pacific Region 0 1972
Mr. Ramon Fuenmayor President South America Region 0 0
Ms. Lisa A. Escudero Senior Vice President of Human Resources 0 1962
Lista ETF z ekspozycją na akcje Phibro Animal Health Corporation
Symbol ETF Ilość akcji Wartość
IJR 1 286 874 34 102 158
IWM 518 907 13 751 046
IWO 190 807 5 056 395
IJT 187 879 4 978 806
SPSM 180 331 5 047 318
VTWO 104 148 2 659 939
DES 102 253 2 709 704
SLYG 101 001 2 820 409
SCHA 94 864 2 621 093
XSMO 94 715 2 644 442
VIOO 67 529 1 724 690
FSMD 65 161 1 884 456
VHT 62 323 1 591 729
VFMO 56 177 1 434 760
DFAS 53 100 1 407 150
RWJ 52 615 1 469 010
DFAC 52 149 1 381 948
FESM 50 448 1 458 956
IWC 49 015 1 298 894
XPH 47 751 1 341 565
PRFZ 46 110 1 287 391
BSMC 44 879 1 189 293
ESML 37 982 1 060 457
SXRG.DE 34 424 798 018
CUSS.L 34 424 912 230
CUS1.L 34 424 690 448
CSUSS.MI 34 424 798 018
ISP6.L 31 693 635 674
IUS3.DE 31 693 734 710
IDP6.L 31 693 839 861
R2SC.L 30 304 641 156
R2US.L 30 304 846 087
ZPRR.DE 30 304 740 918
ITOT 29 873 791 643
RZG 26 846 749 540
EES 25 245 668 992
NUSC 24 834 549 328
VIOG 24 258 619 549
IUSN.DE 23 992 556 192
WSML.L 23 992 635 794
WLDS.L 23 992 481 219
VFMF 23 806 608 005
GSSC 23 261 730 162
PSCH 19 528 545 221
PSC 19 480 516 220
VTWG 18 023 460 307
SMLV 14 550 410 728
BTEE.L 12 811 339 479
2B70.DE 12 811 296 976
BTEC.L 12 811 339 479
BTEK.L 12 811 256 945
XRS2.DE 12 424 288 309
XRSU.L 12 424 329 232
XRSG.L 12 424 24 948 920
SCHB 11 372 316 310
RSSL 10 371 274 831
ROSC 8 937 249 521
FHLC 8 638 249 810
IJR.AX 7 222 312 076
WSCR.L 6 344 177 683
EHLS 5 900 164 728
DFAU 4 537 120 230
IWV 3 990 105 733
XSU.TO 3 542 136 571
QVMS 3 308 92 359
SPTM 3 222 90 150
ZPRV.DE 2 809 59 824
USSC.L 2 809 68 316
OMFS 2 664 74 378
SQLV 2 590 72 312
UWM 2 070 54 855
DCOR 2 068 54 802
VTHR 1 817 46 406
PILL 1 749 46 348
URTY 1 713 45 394
DFUV 1 684 44 626
CBUG.DE 1 676 38 859
EWSA.AS 1 676 44 420
XJR 1 632 45 565
FLQS 1 608 44 895
QQQS 1 537 42 913
WOSC.L 1 300 27 504
WDSC.L 1 300 36 296
ZPRS.DE 1 300 31 784
VLU 954 26 786
XUU.TO 914 35 236
BIB 751 19 901
IBBQ 724 20 214
XSMC.TO 721 27 791
XSMH.TO 667 25 706
AVSC 409 11 419
SAA 375 9 937
XGRO.TO 355 13 702
BUYO 280 7 420
EBIT 218 6 086
XBAL.TO 164 6 308
ESIX 156 4 380
XUH.TO 135 3 766
MMTM 48 1 337
HDG 25 662
DXUV 22 583
XCNS.TO 13 494
XTR.TO 5 152
SC0K.DE 0 45 007
USML.L 0 70 270
PZW.TO 0 6 024
SBIO.L 0 158 077
USFM.L 0 0
RTYS.L 0 51 366
USUE.DE 0 0
SBIO.MI 0 138 507
Wiadomości dla Phibro Animal Health Corporation
Tytuł Treść Źródło Aktualizacja Link
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. zacks.com 2025-05-13 14:46:10 Czytaj oryginał (ang.)
International Markets and Phibro (PAHC): A Deep Dive for Investors Examine the evolution of Phibro's (PAHC) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects. zacks.com 2025-05-13 14:20:50 Czytaj oryginał (ang.)
3 Reasons Growth Investors Will Love Phibro (PAHC) Phibro (PAHC) is well positioned to outperform the market, as it exhibits above-average growth in financials. zacks.com 2025-05-12 17:50:48 Czytaj oryginał (ang.)
PAHC or BSX: Which Is the Better Value Stock Right Now? Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks? zacks.com 2025-05-12 16:46:03 Czytaj oryginał (ang.)
Should Value Investors Buy Phibro Animal Health (PAHC) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com 2025-05-12 14:45:48 Czytaj oryginał (ang.)
Phibro Animal Health Corporation (PAHC) Q3 2025 Earnings Call Transcript Phibro Animal Health Corporation (NASDAQ:PAHC ) Q3 2025 Earnings Conference Call May 8, 2025 9:00 AM ET Company Participants Glenn David - Chief Financial Officer Jack Bendheim - Chairman-Board of Directors, President & Chief Executive Officer Conference Call Participants Ekaterina Knyazkova - JPMorgan Michael Ryskin - Bank of America Navann Ty - BNP Paribas Operator Hello and thank you for standing by. My name is Regina [ph] and I will be your conference operator today. seekingalpha.com 2025-05-10 19:40:26 Czytaj oryginał (ang.)
Phibro Q3 Earnings Top Estimates, Stock Up, 2025 EPS Outlook Raised PAHC's third-quarter fiscal 2025 results reflect the strength of the Animal Health segment. zacks.com 2025-05-08 13:15:38 Czytaj oryginał (ang.)
Compared to Estimates, Phibro (PAHC) Q3 Earnings: A Look at Key Metrics Although the revenue and EPS for Phibro (PAHC) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers. zacks.com 2025-05-08 01:35:32 Czytaj oryginał (ang.)
Phibro Animal Health (PAHC) Q3 Earnings Beat Estimates Phibro Animal Health (PAHC) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.52 per share. This compares to earnings of $0.31 per share a year ago. zacks.com 2025-05-08 00:40:29 Czytaj oryginał (ang.)
Phibro Animal Health Corporation Reports Third Quarter Results, Updates Financial Guidance TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) (“Phibro” or the “Company”) today announced financial results for its third quarter ended March 31, 2025, and its updated financial guidance for the year ending June 30, 2025. Highlights for the three months ended March 31, 2025 (compared to the three months ended March 31, 2024) Net sales of $347.8 million, an increase of $84.6 million, or 32% Net income of $20.9 million, an increase of $12.5 million Diluted earnin. businesswire.com 2025-05-07 20:30:00 Czytaj oryginał (ang.)
Phibro Animal Health Corporation Declares Quarterly Dividend TEANECK, N.J.--(BUSINESS WIRE)--The Board of Directors of Phibro Animal Health Corporation (Nasdaq: PAHC) today declared a quarterly cash dividend of $0.12 per share on its Class A common stock and Class B common stock, payable on June 25, 2025, to stockholders of record at the close of business on June 4, 2025. About Phibro Animal Health Corporation Phibro Animal Health Corporation is a leading global diversified animal health and nutrition company. We strive to be a trusted partner with lives. businesswire.com 2025-05-06 20:15:00 Czytaj oryginał (ang.)
Phibro Animal Health (PAHC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release Phibro (PAHC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations. zacks.com 2025-04-30 15:06:14 Czytaj oryginał (ang.)
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. zacks.com 2025-04-24 14:40:38 Czytaj oryginał (ang.)
Phibro Animal Health Corporation to Host Webcast and Conference Call on Third Quarter Results TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) expects to announce its third quarter financial results on Wednesday, May 7, 2025, after the market closes. Phibro management will host a conference call and webcast on Thursday, May 8, 2025, at 9:00 AM Eastern Time. Interested parties are invited to listen to the conference call and view the presentation slides by visiting https://investors.pahc.com. The discussion will also be available by dialing +1 (888) 330-202. businesswire.com 2025-04-23 20:00:00 Czytaj oryginał (ang.)
PAHC or BSX: Which Is the Better Value Stock Right Now? Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Boston Scientific (BSX). But which of these two companies is the best option for those looking for undervalued stocks? zacks.com 2025-04-16 16:46:23 Czytaj oryginał (ang.)
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com 2025-04-16 14:46:23 Czytaj oryginał (ang.)
Here's Why Phibro (PAHC) is Poised for a Turnaround After Losing -22.25% in 4 Weeks Phibro (PAHC) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock. zacks.com 2025-04-16 14:35:37 Czytaj oryginał (ang.)
Here's Why Phibro (PAHC) is Poised for a Turnaround After Losing -13.52% in 4 Weeks The heavy selling pressure might have exhausted for Phibro (PAHC) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal. zacks.com 2025-04-11 14:35:35 Czytaj oryginał (ang.)
Here is Why Growth Investors Should Buy Phibro (PAHC) Now Phibro (PAHC) could produce exceptional returns because of its solid growth attributes. zacks.com 2025-04-09 17:45:38 Czytaj oryginał (ang.)
Top 3 MedTech Stocks to Weather the Trump Tariff Turbulence In the present market turbulence, investors may want to consider discounted stocks, such as FMS, PAHC and COR. zacks.com 2025-04-09 14:01:13 Czytaj oryginał (ang.)
3 Strong Buy Stocks for the Momentum Investor Brinker International, AppLovin and Phibro Animal Health have been selected as the momentum picks for the day using the Driehaus strategy. zacks.com 2025-02-26 18:05:26 Czytaj oryginał (ang.)
3 Reasons Why Growth Investors Shouldn't Overlook Phibro (PAHC) Phibro (PAHC) possesses solid growth attributes, which could help it handily outperform the market. zacks.com 2025-02-26 15:45:41 Czytaj oryginał (ang.)
PAHC or SYK: Which Is the Better Value Stock Right Now? Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Stryker (SYK). But which of these two stocks offers value investors a better bang for their buck right now? zacks.com 2025-02-26 14:45:41 Czytaj oryginał (ang.)
Bears are Losing Control Over Phibro (PAHC), Here's Why It's a 'Buy' Now Phibro (PAHC) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term. zacks.com 2025-02-26 13:01:17 Czytaj oryginał (ang.)
Should Value Investors Buy Phibro Animal Health (PAHC) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com 2025-02-26 12:45:36 Czytaj oryginał (ang.)
5 High Earnings Yield Value Stocks to Buy Amid Market Volatility Volatility looms with sticky inflation, a slowing economy and Trump's trade policies. Buy high-earnings-yield stocks like NUS, HRMY, PAHC, DAN and NRG. zacks.com 2025-02-24 11:10:32 Czytaj oryginał (ang.)
Phibro Animal Health Corporation to Participate at Bank of America 2025 Virtual Animal Health Summit TEANECK, N.J.--(BUSINESS WIRE)--Phibro Animal Health Corporation (Nasdaq: PAHC) announced today it will participate in the Bank of America 2025 Virtual Animal Health Summit. Chief Financial Officer, Glenn David will address financial analysts and investors on Thursday, February 27, 2025, at 10:50 AM ET. The live audio presentation will be available on the Phibro Animal Health Corporation Investor Relations Website at https://investors.pahc.com. A replay of the session will be available and arch. businesswire.com 2025-02-20 18:00:00 Czytaj oryginał (ang.)
4 PEG-Based Value Stocks to Shield Your Portfolio From Trade War Here are four PEG-driven GARP stocks, GM, EXPE, PAHC and PPC, which qualify our screening criteria. zacks.com 2025-02-14 13:56:12 Czytaj oryginał (ang.)
Best Momentum Stocks to Buy for February 14th FINW, SFTBY and PAHC made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on February 14, 2025. zacks.com 2025-02-14 13:01:21 Czytaj oryginał (ang.)
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. zacks.com 2025-02-14 12:41:30 Czytaj oryginał (ang.)
4 Stocks Trading Near 52-Week High With More Upside Potential Stocks like NFG, ENS, PAHC and C are seeing price strength and have a high chance of carrying the momentum forward. zacks.com 2025-02-14 11:00:35 Czytaj oryginał (ang.)
New Strong Buy Stocks for February 14th FRSH, SFTBY, ATGE, FINW and PAHC have been added to the Zacks Rank #1 (Strong Buy) List on February 14, 2025. zacks.com 2025-02-14 08:46:07 Czytaj oryginał (ang.)
Best Value Stocks to Buy for February 14th ATGE and PAHC made it to the Zacks Rank #1 (Strong Buy) value stocks list on February 14, 2025. zacks.com 2025-02-14 07:40:22 Czytaj oryginał (ang.)
Best Income Stocks to Buy for February 14th PAHC made it to the Zacks Rank #1 (Strong Buy) income stocks list on February 14, 2025. zacks.com 2025-02-14 06:46:06 Czytaj oryginał (ang.)
Phibro Animal Health Is Cruising With Its Recent Zoetis Acquisition Phibro Animal Health delivers animal health and nutritional solutions through feed additives, vaccines, and performance products. The Zoetis acquisition added 37 product lines, driving a 24% increase in net sales and 64% growth in adjusted EBITDA. The company projects strong revenue growth in 2025 with expanding margins and updated EPS guidance. seekingalpha.com 2025-02-13 10:15:00 Czytaj oryginał (ang.)
Phibro Animal Health (PAHC) Is Up 8.62% in One Week: What You Should Know Does Phibro Animal Health (PAHC) have what it takes to be a top stock pick for momentum investors? Let's find out. zacks.com 2025-02-11 15:01:12 Czytaj oryginał (ang.)
Phibro Animal Health Corporation (PAHC) Hits Fresh High: Is There Still Room to Run? Phibro (PAHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. zacks.com 2025-02-11 12:16:17 Czytaj oryginał (ang.)
Is Phibro (PAHC) a Solid Growth Stock? 3 Reasons to Think "Yes" Phibro (PAHC) is well positioned to outperform the market, as it exhibits above-average growth in financials. zacks.com 2025-02-10 15:46:15 Czytaj oryginał (ang.)
PAHC vs. GEHC: Which Stock Is the Better Value Option? Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and GE HealthCare Technologies (GEHC). But which of these two stocks is more attractive to value investors? zacks.com 2025-02-10 14:46:33 Czytaj oryginał (ang.)
Are Investors Undervaluing Phibro Animal Health (PAHC) Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com 2025-02-10 12:47:30 Czytaj oryginał (ang.)
Reasons to Retain Phibro Stock in Your Portfolio Now PAHC's prospering Vaccine business sparks optimism for future growth. However, headwinds such as unfavorable foreign exchange might hamper the company's operations. zacks.com 2025-01-03 10:51:14 Czytaj oryginał (ang.)
Phibro Animal Health Gains 83% in a Year: What's Driving the Stock? PAHC shares gain owing to the remarkable performance of the Animal Health business and potential in the emerging markets. zacks.com 2025-01-03 10:05:41 Czytaj oryginał (ang.)
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. zacks.com 2024-12-27 12:41:18 Czytaj oryginał (ang.)
Why Phibro Animal Health (PAHC) is a Top Value Stock for the Long-Term The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. zacks.com 2024-12-11 12:46:35 Czytaj oryginał (ang.)
Should Value Investors Buy Phibro Animal Health (PAHC) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com 2024-12-09 12:46:33 Czytaj oryginał (ang.)
4 Medical Product Stocks to Buy From a Prospective Industry An ongoing rise in demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. RMD, HAE, PAHC and AGIO are well-poised to gain from the favorable factors. zacks.com 2024-12-04 12:45:35 Czytaj oryginał (ang.)
Reasons to Add Phibro Stock to Your Portfolio Right Now PAHC's Animal Health business, along with flourishing Mineral Nutrition and Performance Product businesses, sparks optimism for future growth. zacks.com 2024-12-02 11:10:27 Czytaj oryginał (ang.)
Here is Why Growth Investors Should Buy Phibro (PAHC) Now Phibro (PAHC) is well positioned to outperform the market, as it exhibits above-average growth in financials. zacks.com 2024-11-29 15:51:11 Czytaj oryginał (ang.)
Why Phibro Animal Health (PAHC) is a Top Momentum Stock for the Long-Term Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. zacks.com 2024-11-26 12:55:30 Czytaj oryginał (ang.)
PAHC vs. ABT: Which Stock Is the Better Value Option? Investors interested in Medical - Products stocks are likely familiar with Phibro Animal Health (PAHC) and Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck right now? zacks.com 2024-11-25 14:46:37 Czytaj oryginał (ang.)
Should Value Investors Buy Phibro Animal Health (PAHC) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com 2024-11-21 12:45:40 Czytaj oryginał (ang.)
Looking for a Growth Stock? 3 Reasons Why Phibro (PAHC) is a Solid Choice Phibro (PAHC) possesses solid growth attributes, which could help it handily outperform the market. zacks.com 2024-11-12 15:50:25 Czytaj oryginał (ang.)
Phibro Animal Health Corporation (PAHC) Hits Fresh High: Is There Still Room to Run? Phibro (PAHC) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. zacks.com 2024-11-12 12:15:18 Czytaj oryginał (ang.)
Investing in Phibro (PAHC)? Don't Miss Assessing Its International Revenue Trends Explore Phibro's (PAHC) international revenue trends and how these numbers impact Wall Street's forecasts and what's ahead for the stock. zacks.com 2024-11-11 12:21:04 Czytaj oryginał (ang.)
Phibro Animal Health Corporation (PAHC) Q1 2025 Earnings Call Transcript Phibro Animal Health Corporation (NASDAQ:PAHC ) Q1 2025 Earnings Conference Call November 7, 2024 9:00 AM ET Company Participants Glenn David - Chief Financial Officer Jack Bendheim - Chairman-Board of Directors, President & Chief Executive Officer Daniel Bendheim - Director & Executive Vice President-Corporate Strategy Larry Miller - Chief Operating Officer Conference Call Participants Ekaterina Knyazkova - JPMorgan Michael Ryskin - Bank of America Navann Ty - BNP Paribas Operator Hello, and thank you for standing by. My name is Regina and I will be your conference operator today. seekingalpha.com 2024-11-08 22:31:36 Czytaj oryginał (ang.)
Here's Why Phibro Animal Health (PAHC) is a Strong Value Stock Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. zacks.com 2024-11-08 12:46:36 Czytaj oryginał (ang.)
PAHC or ABT: Which Is the Better Value Stock Right Now? Investors looking for stocks in the Medical - Products sector might want to consider either Phibro Animal Health (PAHC) or Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck right now? zacks.com 2024-11-07 14:40:33 Czytaj oryginał (ang.)
Phibro's Q1 Earnings Top Estimates, Stock Up, Net Sales Surge Y/Y PAHC delivers strong growth across all its segments in the first quarter of fiscal 2025. zacks.com 2024-11-07 11:30:28 Czytaj oryginał (ang.)
Phibro (PAHC) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates While the top- and bottom-line numbers for Phibro (PAHC) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. zacks.com 2024-11-06 22:36:24 Czytaj oryginał (ang.)
Phibro Animal Health (PAHC) Tops Q1 Earnings Estimates Phibro Animal Health (PAHC) came out with quarterly earnings of $0.35 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.14 per share a year ago. zacks.com 2024-11-06 21:51:08 Czytaj oryginał (ang.)